We evaluated CYR61 and TAZ as early biomarkers of BE progression in a validation set of FFPE samples from 19 BE patients (detailed characteristics of the patients used in the validation set of the present study is available in S1 Table). Here, WWTR1 is linked to Barrett esophagus.